CAMP - cathelicidin antimicrobial peptide Gene

Homo sapiens

Also known as LL37; CAP18; CRAMP; HSD26; CAP-18; FALL39; FALL-39

Gene ID: 820 | Gene type: protein coding

About CAMP

Cytogenetic location: 3p21.31 Genomic coordinates (GRCh38): 3:48,223,495-48,225,485 (from NCBI)

This gene has 2 transcripts (splice variants) and 249 orthologues. Restricted expression toward bone marrow (RPKM 591.5).

Summary

This gene encodes a member of an antimicrobial peptide family, characterized by a highly conserved N-terminal signal peptide containing a cathelin domain and a structurally variable cationic antimicrobial peptide, which is produced by extracellular proteolysis from the C-terminus. The protein plays an important role in innate immunity defense against viruses. In addition to its Antibacterial, Antifungal, and Antiviral activities, the encoded protein functions in cell chemotaxis, immune mediator induction, and inflammatory response regulation. [provided by RefSeq, Sep 2021]

CAMP Products(1)

mRNA	Protein	Name
NM_004345.5	NP_004336.4	cathelicidin antimicrobial peptide preproprotein

CAMP Protein Structure

Cathelicidins

CAP18_C

0
100
170 a.a.

Protein Preferred Names

Protein Names

cathelicidin antimicrobial peptide

18 kDa cationic antimicrobial protein

Related Diseases

Diseases

Alias

Rosacea

Erythematotelangiectatic Rosacea	Papulopustular Rosacea
Phymatous Rosacea	Acne Roscea
Acne, Erythematosa	Granulomatous Rosacea
Ocular Rosacea	Acne Rosacea
Hypertrophic Rosacea

Cellulitis

Facial Dermatosis

Facial Dermatoses

Mycobacterium Marinum

Mycobacterium Marinum Infection	Fish Tank Granuloma
M. Marinum

Bacterial Infectious Disease

Bacterial Infections	Bacterial Infection Nos
Disease Caused By Bacteria	Bacterial Disease Or Disorder

Severe Congenital Neutropenia 3

Kostmann Syndrome	Infantile Agranulocytosis
Kostmann Disease	Scn3
Severe Congenital Neutropenia Type 3

Hidradenitis Suppurativa

Acne Inversa	Suppurative Hidradenitis
Acne Inversa, Familial	Apocrinitis
Hidradenitides, Suppurative	Hidradenitis, Suppurative
Suppurative Hidradenitides	Inverse Acne

Hidradenitis

Hydradenitis

Cystic Fibrosis

Mucoviscidosis	CF
Pseudomonas Aeruginosa, Susceptibility To Chronic Infection By, In Cystic Fibrosis	Pseudomonas Aeruginosa Chronic Infection By, In Cystic Fibrosis
Cystic Fibrosis Lung Disease, Modifier Of	Cystic Fibrosis Of Pancreas
Fibrocystic Disease Of Pancreas	Cf - [Cystic Fibrosis]
Cystic Fibrosis Nos	Fibrocystic Disease
Fibrocystic Disease Of The Pancreas	Mucoviscidosis Of Pancreas
Nonproliferative Fibrocystic Disease	Pancreatic Cystic Fibrosis

Dermatitis, Atopic

Atopic Dermatitis	Atopic Eczema
Dermatitis, Atopic, Susceptibility To, 1	Atod
Eczema, Atopic	Dermatitis, Atopic 1
Allergic Dermatitis	Atopic Neurodermatitis
Besnier'S Prurigo	Dermatitis, Atopic, 1
Dermatitis Atopic	Eczema
Besnier Prurigo

Psoriasis

Necrotizing Fasciitis

Fasciitis, Necrotizing

Coffin-Lowry Syndrome

CLS	Coffin Syndrome 1
Coffin Syndrome	Intellectual Disability With Osteocartilaginous Abnormalities
Dwarfism, Lean Spastic Type	Lean Spastic Dwarfism
Mental Retardation With Osteocartilaginous Abnormalities	Coffin Lowry Syndrome

Skin Disease

Skin Diseases	Genodermatosis
Abnormality Of The Skin	Skin Diseases, Genetic
Skin And Subcutaneous Tissue Disease	Dermatologic Disorders

Disease By Infectious Agent

Infectious Disease

Infectious Diseases

Papillon-Lefevre Syndrome

Papillon-Lefevre Disease	Papillon-Lefèvre Syndrome
PLS	Keratosis Palmoplantaris With Periodontopathia
PALS	Papillon Lefevre Syndrome
Keratosis Palmoplantar-Periodontopathy Syndrome	Papillon-Lefvre Syndrome
Hyperkeratosis Palmoplantaris With Periodontosis	Keratoris Palmoplantaris With Periodontopathia
Keratosis Palmoplantar - Periodontopathy	Palmar-Plantar Hyperkeratosis And Concomitant Periodontal Destruction
Palmoplantar Keratoderma With Periodontosis	Palsy

Toxic Shock Syndrome

Septic Shock	Toxic Shock
Tss	Shock, Septic
Staphylococcal Toxic Shock Syndrome	Tss - [Toxic Shock Syndrome]

Eczema Herpeticum

Herpes Simplex Dermatitis	Herpes Simplex Eyelid Dermatitis
Kaposi Varicelliform Eruption	Herpes Simplex Dermatitis Of Eyelid
Herpes Simplex Virus Dermatitis	Herpes Simplex Virus Eyelid Dermatitis

Denture Stomatitis

Stomatitis, Denture

Denture Sore Mouth

Autoimmune Disease Of Skin And Connective Tissue

Impetigo

Polycystic Kidney Disease

Polycystic Kidney Diseases	Pkd
Polycystic Renal Disease	Kidney Disease, Polycystic
Polycystic Kidney, Autosomal Dominant

Sebaceous Gland Disease

Sebaceous Gland Anomaly

Sebaceous Gland Diseases

Vaginal Disease

Vaginal Diseases

Shigellosis

Dysentery, Bacillary	Bacillary Dysentery
Shigella Boydii Infectious Disease	Shigella Flexneri Infectious Disease
Shigella Gastroenteritis	Shigella Sonnei Infectious Disease
Shigella Infections

Mycobacterium Tuberculosis 1

Tuberculosis	Tuberculoma
Tuberculosis, Susceptibility To	Mycobacterium Tuberculosis, Susceptibility To, 1
Mtbs1	TB

Contact Dermatitis

Contact Dermatitis/Eczema	Contact Eczema
Dermatitis Venenata	Dermatitis, Venenata
Dermatitis Contact	Dermatitis, Contact

Chancroid

Ulcus Molle, Skin	Chancroids
Bubo Due To Haemophilus Ducreyi	Soft Chancre
Ulcus Molle

Vaginitis

Infective Vaginitis	Inflammation Of Vagina
Colpitis	Vaginal Inflammation
Vaginitis Nos

Fallopian Tube Disease

Fallopian Tube Diseases

Tinea Pedis

Athlete'S Foot	Dermatophytosis Of Foot
Ringworm Of Foot	Moccasin Foot

Dermatophytosis

Tinea	Dermatophytosis, Unspecified
Ringworm	Infections Due To Species Of Epidermophyton, Microsporum And Trichophyton
Cutaneous Mycosis	Dermal Mycosis
Superficial Mycosis, Unspecified	Fungus Infection Of Skin
Skin Mycosis	Dermatitis Fungoid
Fungal Dermatitis	Fungal Dermatosis
Mycotic Infection Of Skin

Allergic Contact Dermatitis

Dermatitis, Allergic Contact	Contact Dermatitis, Allergic
Dermatitis Allergic Contact	Allergic Contact Eczema
Acd - [Allergic Contact Dermatitis]	Allergic Contact Dermatitis, Unspecified Cause
Allergic Dermatitis	Allergic Eczema
Allergy Dermatitis	Allergy Eczema
Allergic Contact Eczema Due To Clothing Or Footwear	Perfume Allergic Contact Dermatitis
Allergic Contact Dermatitis Due To Cosmetics	Allergic Contact Eczema Due To Cosmetics Or Fragrances
Allergic Contact Eczema Due To Dental Materials	Allergic Contact Eczema Due To Food Flavours Or Additives
Allergic Contact Eczema Due To Hairdressing Products	Allergic Contact Eczema Due To Metals Or Metal Salts
Allergic Contact Eczema Due To Proteins	Allergic Contact Eczema Due To Plastics Or Resin Systems
Allergic Contact Eczema Due To Preservatives Or Biocides	Allergic Contact Eczema Due To Rubber Chemicals
Rubber Dermatitis	Allergic Contact Eczema Due To Systemic Medicaments
Allergic Contact Eczema Due To Topical Medicaments	Allergic Contact Dermatitis Due To Drugs In Contact With Skin

Endocardium Disease

Colorectal Cancer

Colon Cancer	Colorectal Carcinoma
Colon Carcinoma	Colorectal Cancer, Susceptibility To
Carcinoma Of Colon	CRC
Colorectal Cancer With Chromosomal Instability, Somatic	Colon Cancer, Somatic
Colon Cancer, Susceptibility To	Colonic Neoplasms
Colorectal Neoplasms	Colorectal Cancer, Somatic
Colon Cancer, Advanced, Somatic	Colonic Carcinoma
Colorectal Carcinomas	Colon Cancers
Colorectal Cancers	Cancer, Colorectal, Somatic
Cancer, Colon	Cancer, Colorectal, Susceptibility To
Colorectal Neoplasm	Colonic Neoplasm
Malignant Tumor Of Colon

Urethritis

Nonspecific Urethritis	Non-Gonococcal Urethritis
Nongonococcal Urethritis

Gingival Disease

Gingival Diseases	Gum Disease
Gingival Disorder	Gingivitis And Periodontal Diseases

Asthma

Chronic Obstructive Asthma	Asthma, Diminished Response To Antileukotriene Treatment In
Bronchial Hyperreactivity	Asthma, Susceptibility To
Asthma, Bronchial	Asthma, Protection Against
Asthma, Nocturnal, Susceptibility To	Nocturnal Asthma
Asthma-Related Traits	Asthma-Related Traits, Susceptibility To
Asthma, Nocturnal	Chronic Obstructive Asthma With Acute Exacerbation
Chronic Obstructive Asthma With Status Asthmaticus	Exercise Induced Asthma
Exercise-Induced Asthma	Bronchial Asthma
Asthma, Exercise-Induced	Idiosyncratic Asthma
Unspecified Asthma With Acute Exacerbation	Asthma, Unspecified, With Stated Status Asthmaticus
Status Asthmaticus Nos	Acute Severe Asthma
Acute Severe Bronchial Asthma	Status Asthma
Status Post Asthmaticus

Telangiectasis

Telangiectasia

Urinary Tract Infection

Urinary Tract Infections	Uti
Urinary Tract Infection Nos	Uti - [Urinary Tract Infection]
Uti Nos - [Urinary Tract Infection Nos]	Urosepsis Nos
E Coli Uti	E Coli Urinary Tract Infection
Escherichia Coli Uti

Severe Congenital Neutropenia

Congenital Neutropenia	Neutropenia, Severe Congenital
Congenital Agranulocytosis	Infantile Genetic Agranulocytosis
Kostmann Disease	Kostmann'S Agranulocytosis
Kostmann'S Syndrome	Severe Infantile Genetic Neutropenia

Scleredema Adultorum

Scleredema	Buschke'S Scleredema
Scleredema Adultorum Of Buschke	Scleredema Diabeticorum
Scleredema Diabeticorum Of Buschke	Buschke Scleredema

Integumentary System Disease

Inflammatory Bowel Disease

Inflammatory Bowel Diseases

Bowel Disease, Inflammatory

Primary Bacterial Infectious Disease

Polycystic Kidney Disease 4 With Or Without Polycystic Liver Disease

Autosomal Recessive Polycystic Kidney Disease	Arpkd
Polycystic Kidney Disease, Autosomal Recessive	Polycystic Kidney And Hepatic Disease 1
Pkhd1	PKD4
Polycystic Kidney Disease 4 With Or Without Hepatic Disease	Polycystic Kidney Disease, Infantile, Type I
Polycystic Kidney Disease, Infantile Type	Polycystic Kidney, Autosomal Recessive
Pkd3, Formerly	Polycystic Kidney Disease 4, With Or Without Hepatic Disease
Arpkd/Chf	Ar-Pkd
Polycystic Kidney Disease 4, With Or Without Polycystic Liver Disease	Infantile Polycystic Kidney Disease Type I
Pkd3	Kidney, Polycystic, Disease, Type 4, With/Without Hepatic Disease
Polycystic Kidney Disease 3, Autosomal Dominant

Acute Promyelocytic Leukemia

Leukemia, Acute Promyelocytic	Acute Myeloblastic Leukemia Type 3
Aml M3	APL
Leukemia, Acute Promyelocytic, Somatic	Aml With T(15
17)(Q22	Q12)
(Pml/Raralpha) And Variants	Apml
Acute Myeloblastic Leukemia 3	Acute Myeloid Leukemia With T(15
17)(Q22	Q12)
(Pml/Raralpha) And Variants	Acute Myeloblastic Leukaemia Type 3
Acute Myeloid Leukaemia M3	Acute Myeloid Leukemia M3
Acute Promyelocytic Leukaemia	M3 Anll
Myeloid Leukemia, Acute, M3	Leukemia Promyelocytic Acute
Leukemia, Promyelocytic, Acute	Leukemia, Acute, Promyelocytic

Related Agents

Approval

Bioactive Molecules (24)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-B0764	Bucladesine sodium		99.48%	Yes
HY-Y0682	Ethylenediaminetetraacetic acid		≥98.0%	Unkown
HY-P0036	Octreotide		99.64%	Unkown
HY-14773	Mirabegron	Agonist	99.90%	Yes
HY-14302	Salmeterol	Agonist	99.91%	Yes
HY-B0764A	Bucladesine calcium		99.52%	Yes
HY-108742A	Abaloparatide TFA	Activator	99.86%	Unkown
HY-17592	Bithionol	Inhibitor	99.27%	Unkown
HY-128932	Cefminox sodium		99.83%	Unkown
HY-17034B	Medetomidine hydrochloride	Agonist	99.92%	Unkown
HY-108742	Abaloparatide	Activator	99.94%	Unkown
HY-Y0682A	Ethylenediaminetetraacetic acid disodium dihydrate		≥98.0%	Unkown
HY-17453	Salmeterol xinafoate	Agonist	99.96%	Yes
HY-17034	Medetomidine	Agonist	99.99%	Unkown
HY-B1898	Metadoxine		99.88%	Yes
HY-B1481	Isoetharine mesylate	Agonist	99.87%	Unkown
HY-B1505	Acefylline		99.96%	Unkown
HY-B1639	Enoximone	Inhibitor	98.07%	Unkown
HY-B1009	Ethylenediaminetetraacetic acid trisodium salt		≥98.0%	Unkown
HY-B1209	Etofylline	Inhibitor	99.72%	Unkown
HY-B0813	Treprostinil diethanolamine	Agonist	99.44%	Yes
HY-B1481A	Isoetharine	Agonist	/	Unkown
HY-B0764B	Bucladesine	Activator	/	Unkown
HY-P0036B	Octreotide pamoate		/	Unkown

Clinical Phase

Bioactive Molecules (21)

Cat. No.	Product Name	Effect	Purity	Phase
HY-W105700	Ethylenediaminetetraacetic acid sodium hydrate		≥98.0%	Phase 4
HY-50906	LY404039	Agonist	≥98.0%	Phase 3
HY-119486A	(Rac)-Tavapadon	Agonist	99.87%	Phase 3
HY-P3366	Ecnoglutide	Agonist	98.61%	Phase 3
HY-16635	Setipiprant	Antagonist	98.23%	Phase 3
HY-130786	Denbufylline	Inhibitor	99.92%	Phase 3
HY-16642A	LY2828360	Agonist	99.50%	Phase 2
HY-12525	LGD-6972	Antagonist	≥98.0%	Phase 2
HY-12887	Piclamilast	Inhibitor	99.63%	Phase 2
HY-109139	Taminadenant	Antagonist	99.84%	Phase 2
HY-100936	Etazolate hydrochloride		98.00%	Phase 2
HY-101189	JNJ-39758979	Antagonist	99.71%	Phase 2
HY-19436	Solabegron	Agonist	99.89%	Phase 2
HY-128656	LML134	Agonist	99.43%	Phase 2
HY-106137	Tofimilast	Inhibitor	/	Phase 2
HY-108047	MK-0873	Inhibitor	/	Phase 2
HY-120547	UCB-11056		/	Phase 2
HY-19755	S-5751	Antagonist	/	Phase 2
HY-10301	MK-3207	Antagonist	99.60%	Phase 1
HY-P2878	Phosphodiesterase I		/	Phase 1
HY-124371	Amentoflavone hexaacetate		/	Phase 1

Pre-clinical Phase

Bioactive Molecules (349)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-15371	Forskolin		99.78%	Unkown
HY-12306	8-Bromo-cAMP sodium salt		99.91%	Unkown
HY-B1511	Cyclic AMP		99.95%	Yes
HY-100403	Ro 67-7476	Agonist	99.67%	Unkown
HY-100927	Ro 20-1724	Inhibitor	99.34%	Unkown
HY-103254	ML221		99.55%	Unkown
HY-124696	PU139	Inhibitor	99.14%	Unkown
HY-125791	cis-Epoxysuccinic acid	Agonist	99.00%	Unkown
HY-P1471	Adrenomedullin (AM) (22-52), human	Antagonist	99.91%	Unkown
HY-103193	NKH477	Activator	99.86%	Unkown
HY-122197	ML339	Antagonist	99.88%	Unkown
HY-149164	BTB09089	Agonist	99.43%	Unkown
HY-100530D	Rp-cAMPS sodium salt	Antagonist	99.98%	Unkown
HY-16558	Butein		99.95%	Unkown
HY-12306A	8-Bromo-cAMP		99.41%	Unkown
HY-103194	KH7	Inhibitor	≥99.0%	Unkown
HY-B1511A	Cyclic AMP sodium		99.97%	Unkown
HY-N6727	Gliotoxin		99.51%	Unkown
HY-128358	MR-L2	Activator	99.23%	Unkown
HY-107543	8-CPT-2Me-cAMP sodium	Activator	99.58%	Unkown
HY-P1290A	PKA Inhibitor Fragment (6-22) amide TFA	Inhibitor	99.77%	Unkown
HY-111673	8-CPT-Cyclic AMP sodium		99.92%	Unkown
HY-117656	ESI-05	Inhibitor	99.94%	Unkown
HY-P0222	PKI(5-24)	Inhibitor	99.94%	Unkown
HY-108539	CE3F4	Inhibitor	≥98.0%	Unkown
HY-103431	A68930 hydrochloride	Agonist	≥98.0%	Unkown
HY-P1291	PKI 14-22 amide,myristoylated	Inhibitor	99.91%	Unkown
HY-P0097A	Nonapeptide-1 acetate salt	Antagonist	98.70%	Unkown
HY-136172	ESI-08	Antagonist	99.25%	Unkown
HY-P10138A	human GIP(3-30), amide TFA	Antagonist	98.82%	Unkown
HY-100984	HA-100	Inhibitor	99.80%	Unkown
HY-108618	BC11-38	Inhibitor	99.42%	Unkown
HY-18740A	Trequinsin hydrochloride	Inhibitor	99.93%	Unkown
HY-117958	HJC0197	Inhibitor	99.58%	Unkown
HY-111385	UNC9994 hydrochloride		98.83%	Unkown
HY-15478	WZ811	Antagonist	99.79%	Unkown
HY-103192	MDL12330A	Inhibitor	99.82%	Unkown
HY-124717	YC-001	Antagonist	99.43%	Unkown
HY-133529	PA-8		97.00%	Unkown
HY-W012980	Isovaleric acid	Activator	≥98.0%	Unkown
HY-100013C	2-PCCA hydrochloride		99.63%	Unkown
HY-129421	PA-9		99.60%	Unkown
HY-101572	MHP	Activator	98.23%	Unkown
HY-B0392	(S)-(+)-Rolipram		99.77%	Unkown
HY-129658A	TT-OAD2	Agonist	99.77%	Unkown
HY-103547	L-168049	Antagonist	99.93%	Unkown
HY-103565	AMN082	Agonist	99.83%	Unkown
HY-10797	CJ-42794	Antagonist	98.96%	Unkown
HY-112612A	RTI-13951-33 hydrochloride		98.56%	Unkown
HY-N2118	Bilobetin	Activator	99.39%	Unkown
HY-14899	Taprenepag	Agonist	98.79%	Unkown
HY-103302	SUN B8155	Agonist	99.24%	Unkown
HY-110218	CW 008	Agonist	98.15%	Unkown
HY-119168	LP-471756	Antagonist	99.69%	Unkown
HY-124571	ZQ-16	Agonist	99.88%	Unkown
HY-14550	TP-10	Inhibitor	99.88%	Unkown
HY-P1845A	PACAP-38 (31-38), human, mouse, rat TFA	Inducer	98.33%	Unkown
HY-14973	Vidupiprant	Antagonist	98.33%	Unkown
HY-103186	MRS-1706	Antagonist	98.07%	Unkown
HY-N0113	Hordenine	Inhibitor	99.88%	Unkown
HY-P0172A	ATI-2341 TFA	Agonist	96.71%	Unkown
HY-P1845	PACAP-38 (31-38), human, mouse, rat	Inducer	99.98%	Unkown
HY-116818	Crebinostat	Inhibitor	99.79%	Unkown
HY-153967	BLU0588	Inhibitor	95.92%	Unkown
HY-156863	GRK2 Inhibitor 2	Inhibitor	98.88%	Unkown
HY-101232	Tiotidine	Antagonist	99.28%	Unkown
HY-124151	Adenosine-2'-monophosphate	Activator	99.91%	Unkown
HY-N3945	Glaucine		99.57%	Unkown
HY-P1291A	PKI 14-22 amide,myristoylated TFA	Inhibitor	99.38%	Unkown
HY-P1595	CREBtide		98.96%	Unkown
HY-18978	GR79236	Agonist	99.89%	Unkown
HY-100530C	Sp-cAMPS sodium salt		99.45%	Unkown
HY-B1511R	Cyclic AMP (Standard)		/	Unkown
HY-P0248	Kemptide		98.81%	Unkown
HY-P10138	human GIP(3-30), amide	Antagonist	98.73%	Unkown
HY-103180	2'-MeCCPA	Agonist	99.79%	Unkown
HY-118941	BAY 73-1449	Antagonist	99.99%	Unkown
HY-P1913A	Calcitonin Gene Related Peptide (CGRP) II, rat TFA	Activator	99.89%	Unkown
HY-102076	0990CL	Inhibitor	≥98.0%	Unkown
HY-116530	9-Cyclopentyladenine monomethanesulfonate	Inhibitor	99.16%	Unkown
HY-116874	SKF 83822	Agonist	98.66%	Unkown
HY-14340	WAY-181187	Agonist	98.07%	Unkown
HY-18286	NCGC00229600	Antagonist	99.67%	Unkown
HY-N2038	3,5,6,7,8,3',4'-Heptemthoxyflavone	Inhibitor	99.85%	Unkown
HY-N2168	Pinoresinol 4-O-β-D-glucopyranoside		99.89%	Unkown
HY-P1296	Urocortin, rat	Agonist	96.58%	Unkown
HY-P2249	ELA-21 (human)		98.92%	Unkown
HY-106358	Andolast free base	Inhibitor	98.09%	Unkown
HY-103322	6-Bnz-cAMP sodium salt	Activator	≥98.0%	Unkown
HY-111896	7-Methoxyrosmanol	Inhibitor	98.56%	Unkown
HY-134598A	653-47 hydrochloride	Inhibitor	99.42%	Unkown
HY-135119	Salmeterol-d3	Inhibitor	98.91%	Unkown
HY-141495	(Rac)-Razpipadon	Agonist	97.09%	Unkown
HY-148867	UCM-1306	Modulator	99.61%	Unkown
HY-N1860	3-O-Methylquercetin	Inhibitor	99.98%	Unkown
HY-P1250	RFRP-3(human)	Agonist	99.21%	Unkown
HY-P2197	ELA-11(human)		99.03%	Unkown
HY-108539A	(R)-CE3F4	Inhibitor	≥99.0%	Unkown
HY-123820	LY3020371 hydrochloride	Antagonist	99.18%	Unkown
HY-106045	Imazodan	Inhibitor	99.38%	Unkown
HY-106739	Motapizone	Inhibitor	≥95.0%	Unkown
HY-113689	GAT211	Agonist	99.98%	Unkown
HY-132240	SF-22	Antagonist	99.49%	Unkown
HY-147395	GPR52 agonist-1		99.76%	Unkown
HY-B1511S	Cyclic AMP-13C5		97.45%	Unkown
HY-N0113B	Hordenine hydrochloride	Inhibitor	99.82%	Unkown
HY-RS16241	Camp Mouse Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-100530B	Sp-cAMPS		/	Unkown
HY-103369	PG01	Activator	≥98.0%	Unkown
HY-108258	PSN 375963	Agonist	99.96%	Unkown
HY-108621	RS-25344 hydrochloride	Inhibitor	99.93%	Unkown
HY-117829	UNC9994		98.06%	Unkown
HY-125957	A-3 hydrochloride	Inhibitor	99.75%	Unkown
HY-131032	KI-7	Agonist	99.16%	Unkown
HY-134266	8-Bromo-AMP		98.81%	Unkown
HY-151392	LPA5 antagonist 2	Antagonist	99.62%	Unkown
HY-161106	OX04528	Agonist	99.71%	Unkown
HY-162734	BRD5075	Inhibitor	/	Unkown
HY-19026	Siguazodan	Inhibitor	≥99.0%	Unkown
HY-P1065	Apelin-36(rat, mouse)		98.07%	Unkown
HY-P1106A	K41498 TFA	Antagonist	98.64%	Unkown
HY-P1597	Malantide		96.37%	Unkown
HY-P4823	pTH (1-37) (human)		99.85%	Unkown
HY-P5189A	His-D-beta-Nal-Ala-Trp-D-Phe-Lys-NH2 TFA		99.31%	Unkown
HY-105118A	Zaldaride maleate	Antagonist	≥98.0%	Unkown
HY-112612	RTI-13951-33		/	Unkown
HY-N0113S	Hordenine-d6	Inhibitor	98.03%	Unkown
HY-100530	Rp-cAMPS triethylammonium salt	Antagonist	99.53%	Unkown
HY-101317	TAN-67 dihydrobromide	Agonist	≥99.0%	Unkown
HY-103178	MRE3008F20	Antagonist	99.70%	Unkown
HY-103565A	AMN082 free base	Agonist	99.07%	Unkown
HY-107544	8-pCPT-2'-O-Me-cAMP-AM	Activator	≥99.0%	Unkown
HY-110003	Arachidonylcyclopropylamide	Agonist	≥98.0%	Unkown
HY-111082	ISAM-140	Inhibitor	99.85%	Unkown
HY-120994	Rp-8-CPT-cAMPS sodium	Antagonist	≥99.0%	Unkown
HY-121541	CB-25		99.02%	Unkown
HY-123396	8-Chloro-cAMP	Modulator	≥99.0%	Unkown
HY-131763	2'-O-MB-cAMP sodium		99.94%	Unkown
HY-132993	Hcyb1	Inhibitor	98.24%	Unkown
HY-156649	Vorbipiprant	Antagonist	99.72%	Unkown
HY-156772	GPR88 agonist 2	Agonist	99.57%	Unkown
HY-401913	endo CNTinh-03	Inhibitor	99.96%	Unkown
HY-N6901	Luteolin 7-sulfate		≥95.0%	Unkown
HY-P10716	Exendin-P5	Activator	/	Unkown
HY-P2197A	ELA-11(human) TFA	Chemical	99.03%	Unkown
HY-130304	8-Isoprostaglandin E2	Activator	≥99.0%	Unkown
HY-126383	Spilanthol		/	Unkown
HY-106358A	Andolast	Inhibitor	/	Unkown
HY-126250	NPD-1335	Inhibitor	98.10%	Unkown
HY-100530A	Rp-cAMPS	Antagonist	/	Unkown
HY-100543	Zenidolol	Antagonist	/	Unkown
HY-100984A	HA-100 hydrochloride	Inhibitor	/	Unkown
HY-101189B	JNJ-39758979 dihydrochloride	Antagonist	/	Unkown
HY-101826A	ER21355 hydrochloride	Inhibitor	/	Unkown
HY-101863	CB-6673567		/	Unkown
HY-105118	Zaldaride	Inhibitor	/	Unkown
HY-106045A	Imazodan hydrochloride	Inhibitor	/	Unkown
HY-107046	UK-432097	Agonist	/	Unkown
HY-107506	Ro 67-4853	Agonist	99.90%	Unkown
HY-107612	GPBAR-A	Agonist	/	Unkown
HY-108258A	PSN 375963 hydrochloride	Agonist	/	Unkown
HY-108626	ML154	Antagonist	98.02%	Unkown
HY-108991	T-0509	Agonist	/	Unkown
HY-110005	Sp-cAMPS triethylamine		/	Unkown
HY-110040	L759633	Agonist	/	Unkown
HY-110070	DL-AP4 sodium	Agonist	/	Unkown
HY-110161	sst2 Receptor agonist-1	Agonist	/	Unkown
HY-110366	WAY-181187 oxalate	Agonist	/	Unkown
HY-112363	Aloisine A		/	Unkown
HY-114539	L-750667 triHydrochloride	Antagonist	/	Unkown
HY-114990	EMD 57439	Inhibitor	/	Unkown
HY-115553	DETQ	Agonist	/	Unkown
HY-115769	1,2-Didecanoylglycerol	Activator	/	Unkown
HY-116119	BDF 9148	Activator	/	Unkown
HY-116312	8-CPT-2'-O-Me-cAMP	Activator	/	Unkown
HY-116445	UNC9975		/	Unkown
HY-116806	AF-2785	Inhibitor	/	Unkown
HY-117181	UK-1745	Inhibitor	/	Unkown
HY-117715	CK-3197		/	Unkown
HY-118175	RG 14921		/	Unkown
HY-120687	A68930	Agonist	/	Unkown
HY-120826	A2AAR/hMAO-B-IN-1	Inhibitor	/	Unkown
HY-120828	Albenatide	Agonist	/	Unkown
HY-120879	PF2562	Agonist	/	Unkown
HY-120994A	Rp-8-CPT-cAMPS	Antagonist	/	Unkown
HY-120994B	Sp-8-CPT-cAMPS	Activator	/	Unkown
HY-123008	Reproterol hydrochloride		/	Unkown
HY-123335	L-796,778	Agonist	/	Unkown
HY-123782	(Rac)-UK-414495	Inhibitor	/	Unkown
HY-125020	NCGC00135472		/	Unkown
HY-126754	Archangelicin	Inhibitor	/	Unkown
HY-12880	HA-100 dihydrochloride	Inhibitor	/	Unkown
HY-129210	KMUP-4		/	Unkown
HY-129658	TT-OAD2 free base	Agonist	/	Unkown
HY-130176	UFP-512		/	Unkown
HY-131768	2'-O-Succinyl-cAMP		≥99.0%	Unkown
HY-134263	8-Br-cAMP-AM	Agonist	/	Unkown
HY-134264	8-Br-2'-O-Me-cAMP		/	Unkown
HY-134283	8-Benzylthio-cAMP	Activator	/	Unkown
HY-134298	8-CPT-6-Phe-cAMP	Activator	/	Unkown
HY-134299	8-CPT-cAMP-AM		/	Unkown
HY-134321	8-Azido-cAMP		/	Unkown
HY-134598	653-47	Inhibitor	/	Unkown
HY-136501	MRS2395	Antagonist	/	Unkown
HY-137308	15(R)-Prostaglandin D2		/	Unkown
HY-137638	Sp-5,6-DCl-cBIMPS	Activator	/	Unkown
HY-137638A	Sp-5,6-DCl-cBIMPS sodium	Activator	/	Unkown
HY-137640A	Sp-8-Br-cAMPS sodium	Agonist	/	Unkown
HY-139486	AM-8123	Agonist	/	Unkown
HY-14132	BMS-665053	Antagonist	/	Unkown
HY-142972	19(S)-HETE	Agonist	/	Unkown
HY-14302S1	Salmeterol-d5	Agonist	/	Unkown
HY-144705	GAT564	Modulator	/	Unkown
HY-14773S	(Rac)-Mirabegron-d5	Agonist	/	Unkown
HY-147751	APJ receptor agonist 6		/	Unkown
HY-147946	PDE1-IN-4	Inhibitor	/	Unkown
HY-148827	GEM-231	Inhibitor	/	Unkown
HY-148827A	GEM-231 sodium	Inhibitor	/	Unkown
HY-149247	Antipsychotic agent-2		/	Unkown
HY-149933	AM841	Activator	/	Unkown
HY-150056	CB1R Allosteric modulator 3		98.05%	Unkown
HY-150057	CB1R Allosteric modulator 4	Modulator	/	Unkown
HY-150073	DS01080522	Inhibitor	/	Unkown
HY-156536	RXFP1 receptor agonist-1		/	Unkown
HY-156537	RXFP1 receptor agonist-2		/	Unkown
HY-156538	RXFP1 receptor agonist-3		/	Unkown
HY-156539	RXFP1 receptor agonist-4		/	Unkown
HY-156540	RXFP1 receptor agonist-5		/	Unkown
HY-156541	RXFP1 receptor agonist-6		/	Unkown
HY-156542	RXFP1 receptor agonist-7		/	Unkown
HY-156543	RXFP1 receptor agonist-8		/	Unkown
HY-158179	A3AR agonist 3	Agonist	/	Unkown
HY-158180	A3AR agonist 4	Agonist	/	Unkown
HY-158181	A3AR agonist 5	Agonist	/	Unkown
HY-160734	Aleniglipron	Agonist	/	Unkown
HY-160864	Torbafylline	Inhibitor	/	Unkown
HY-160921	Capeserod	Agonist	/	Unkown
HY-161107	OX04529	Agonist	/	Unkown
HY-161405	NPFF1-R antagonist 1	Inhibitor	/	Unkown
HY-161506	PDE1-IN-7	Inhibitor	/	Unkown
HY-161817	TGR5 agonist 5	Agonist	/	Unkown
HY-162394	Vasopressin V2 receptor antagonist 2	Antagonist	/	Unkown
HY-162401	AZ7976	Agonist	/	Unkown
HY-162581	FCPR16	Inhibitor	/	Unkown
HY-162735	BRD5080		/	Unkown
HY-162787	Adenosine receptor antagonist 5	Antagonist	/	Unkown
HY-163345	5-HT7R antagonist 2	Antagonist	/	Unkown
HY-163530	GPR41 modulator 1	Modulator	/	Unkown
HY-163651	(R)-Vorbipiprant	Antagonist	/	Unkown
HY-163996	DD202-114	Agonist	98.47%	Unkown
HY-168558	PDE4B/D-IN-4	Inhibitor	/	Unkown
HY-17453S	Salmeterol-d3 xinafoate	Agonist	/	Unkown
HY-17453S1	Salmeterol-13C6 xinafoate	Agonist	/	Unkown
HY-19436A	Solabegron hydrochloride	Agonist	/	Unkown
HY-D1187	2-Aza-ε-cAMP		/	Unkown
HY-D1187A	2-Aza-ε-cAMP sodium		/	Unkown
HY-N0113R	Hordenine (Standard)	Inhibitor	/	Unkown
HY-N1189	DL-Syringaresinol diacetate		/	Unkown
HY-N13132	Hellicoside	Inhibitor	/	Unkown
HY-N2658	5,7-Diacetoxy-8-methoxyflavone	Inhibitor	/	Unkown
HY-N3324	Mangostanol	Inhibitor	/	Unkown
HY-N3464	Isopedicin	Inhibitor	/	Unkown
HY-N3550	Catalponol		/	Unkown
HY-N3773	Dodoviscin A	Inhibitor	/	Unkown
HY-N6256	Ilexsaponin B2	Inhibitor	/	Unkown
HY-N8092	Kushenol B	Inhibitor	/	Unkown
HY-P0097	Nonapeptide-1	Antagonist	99.04%	Unkown
HY-P0172	ATI-2341	Agonist	/	Unkown
HY-P0222A	PKI(5-24) TFA	Inhibitor	/	Unkown
HY-P0252B	α-MSH free acid	Agonist	/	Unkown
HY-P10047	PKItide	Inhibitor	/	Unkown
HY-P1065A	Apelin-36(rat, mouse) TFA		/	Unkown
HY-P10728	B7-33	Agonist	/	Unkown
HY-P1106	K41498	Antagonist	/	Unkown
HY-P1250A	RFRP-3(human) TFA	Agonist	/	Unkown
HY-P1290	PKA Inhibitor Fragment (6-22) amide	Inhibitor	/	Unkown
HY-P1296A	Urocortin, rat TFA	Agonist	/	Unkown
HY-P1325	BWX 46	Agonist	/	Unkown
HY-P1471A	Adrenomedullin (AM) (22-52), human TFA	Antagonist	/	Unkown
HY-P1595A	CREBtide TFA		98.72%	Unkown
HY-P1597A	Malantide TFA		/	Unkown
HY-P1817	PACAP-38 (16-38), human, mouse, rat		/	Unkown
HY-P1913	Calcitonin Gene Related Peptide (CGRP) II, rat	Activator	/	Unkown
HY-P2285	AC 253	Antagonist	/	Unkown
HY-P2847	Urocortin II, mouse	Inhibitor	/	Unkown
HY-P2867	Phosphodiesterase II, Bovine Spleen		/	Unkown
HY-P3544	Lys-[Hyp3]-Bradykinin	Agonist	/	Unkown
HY-P3570	Adipokinetic hormone II (Locusta migratoria)	Inducer	/	Unkown
HY-P3572	Adipokinetic hormone I (Locusta migratoria)	Inducer	/	Unkown
HY-P3770	Phosphate acceptor peptide	Inhibitor	/	Unkown
HY-P3786	H-Arg-Gly-Tyr-Ala-Leu-Gly-OH	Inhibitor	/	Unkown
HY-P3930	PKI (5-24),amide	Inhibitor	/	Unkown
HY-P4497	Prolylserine		/	Unkown
HY-P4817	Human PTH-(1-31)		/	Unkown
HY-Q40876	BBT	Modulator	99.71%	Unkown
HY-RS01870	CAMP Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-W127485	cis-9,10-Methyleneoctadecanoic Acid		/	Unkown
HY-W746031	WAY-181187 hydrochloride	Agonist	/	Unkown
HY-105912	ONO 1082		/	Unkown
HY-111527	PPZ2		/	Unkown
HY-113513	5-HEPE		/	Unkown
HY-114727	PDE7-IN-4		/	Unkown
HY-119333	NNC 11-1607	Agonist	/	Unkown
HY-121249	Capeserod hydrochloride	Agonist	/	Unkown
HY-122189	Akuammine		/	Unkown
HY-122622	PF-04471141 hydrochloride		/	Unkown
HY-123396A	8-Chloro-cAMP sodium	Modulator	/	Unkown
HY-124381	ML10375		/	Unkown
HY-124681	NY0116		/	Unkown
HY-12525A	LGD-6972 sodium	Antagonist	/	Unkown
HY-131421	8-PIP-cAMP	Activator	/	Unkown
HY-131764	2'-O-MB-cGMP sodium	Inhibitor	/	Unkown
HY-131766	2'-O-Me-cAMP		/	Unkown
HY-131772	2-AHA-cAMP		/	Unkown
HY-131777	2-Cl-cAMP		/	Unkown
HY-131823	5,6-DCl-cBIMP	Agonist	/	Unkown
HY-131824	5,6-DM-cBIMP	Agonist	/	Unkown
HY-131842	6-Bn-cAMP	Activator	/	Unkown
HY-131844	6-Bnz-5'-AMP		/	Unkown
HY-134254	8-AHA-cAMP		/	Unkown
HY-134302	8-HA-cAMP	Activator	/	Unkown
HY-134308	8-NBD-cAMP sodium		/	Unkown
HY-134325	8-OH-cAMP	Agonist	/	Unkown
HY-134332	8-pCPT-5'-AMP	Activator	/	Unkown
HY-134340	8-pMeOPT-2'-O-Me-cAMP		/	Unkown
HY-134348	8-pHPT-2'-O-Me-cAMP	Agonist	/	Unkown
HY-134389	6-Phe-cAMP	Activator	/	Unkown
HY-134395	6-MB-cAMP		/	Unkown
HY-134406	6-Cl-cPuMP sodium	Modulator	/	Unkown
HY-136942	DS1	Agonist	/	Unkown
HY-137370	2-Hexynyl-5′-N-ethylcarboxamidoadenosine		/	Unkown
HY-137381	6-Bnz-cAMP	Inhibitor	/	Unkown
HY-137530	8-MA-cAMP	Agonist	/	Unkown
HY-137624	Sp-cAMPS-AM	Activator	/	Unkown
HY-137628	Sp-8-PIP cAMP	Agonist	/	Unkown
HY-137630	Sp-8-pCPT-2'-O-Me-cAMPS	Activator	/	Unkown
HY-137632	Sp-8-Cl-cAMPS		/	Unkown
HY-137635	Sp-6-Phe-cAMPS	Activator	/	Unkown
HY-137640	Sp-8-Br-cAMPS	Agonist	/	Unkown
HY-137640B	Rp-8-Br-cAMPS	Inhibitor	/	Unkown
HY-137641	Sp-8-Br-2'-O-Me-cAMPS	Activator	/	Unkown
HY-137646	Sp-2-Cl-cAMPS		/	Unkown
HY-153542	AP-C6	Inhibitor	/	Unkown
HY-69172	RS-25344	Inhibitor	/	Unkown
HY-B1505A	Acefylline piperazine		/	Unkown
HY-N0113A	Hordenine sulfate		/	Unkown
HY-W394717	BGC-20-1531		/	Unkown
HY-P0291	Kemptide Phospho-Ser5		/	Unkown
HY-U00341	ST4206	Antagonist	/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Felis catus	CAMP	VGNC	VGNC:60340
Mus musculus	CAMP	MGD	MGI:108443
Canis familiaris	CAMP	VGNC	VGNC:38688
Macaca mulatta	CAMP	VGNC	VGNC:84221
Rattus norvegicus	CAMP	RGD	RGD:1559878
Macaca fascicularis	CAMP	NCBI	NCBI:102139204
Others	CAMP	NCBI